Articles in Scholarly Journals [Incomplete List]

1. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses?
   Journal of Immunological Methods, vol. 322, no. 1-2, pp. 1–11, 2007
2. Analyses of immunosenescent markers in patients with autoimmune disease
   Clinical Immunology, vol. 123, no. 2, pp. 209–218, 2007
3. Characterization of mature rat oligodendrocytes: a proteomic approach
   Journal of Neurochemistry, vol. 102, no. 2, pp. 562–576, 2007
4. Journal of Proteome Research, vol. 5, no. 7, pp. 1647–1657, 2006
5. No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosis
   Journal of Neuroimmunology, vol. 171, no. 1-2, pp. 189–192, 2006
6. Effects of IFN-β, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls
   Journal of Neuroimmunology, vol. 177, no. 1-2, pp. 189–200, 2006
7. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-a-induced oligodendrocyte apoptosis
   Journal of Neuroscience Research, vol. 83, no. 5, pp. 763–774, 2006
8. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression
   Journal of Neuroscience Research, vol. 83, no. 8, pp. 1432–1446, 2006
9. Gel-free analysis of the human brain proteome: Application of liquid chromatography and mass spectrometry on biopsy and autopsy samples
   PROTEOMICS, vol. 6, no. 18, pp. 4967–4977, 2006
10. Immunoregulation of Autoimmunity by Natural Killer T Cells
    Human Immunology, vol. 66, no. 12, pp. 1193–1202, 2005
11. Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients
    Immunology Letters, vol. 100, no. 2, pp. 205–210, 2005
12. Arthritis Research & Therapy, vol. 7, no. 3, p. R493, 2005
13. Premature Immunosenescence in Rheumatoid Arthritis and Multiple Sclerosis Patients
    Annals of the New York Academy of Sciences, vol. 1051, no. 1, pp. 255–262, 2005
14. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients
    PROTEOMICS, vol. 4, no. 7, pp. 2117–2124, 2004
15. Cytokine-induced cell death in human oligodendroglial cell lines. II: Alterations in gene expression induced by interferon-? and tumor necrosis factor-?
    Journal of Neuroscience Research, vol. 76, no. 6, pp. 846–861, 2004
16. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-? and TNF-? on apoptosis
    Journal of Neuroscience Research, vol. 76, no. 6, pp. 834–845, 2004
17. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action
    Autoimmunity Reviews, vol. 3, no. 4, pp. 267–275, 2004
18. Effects of Prolactin on Cloned Human T-Lymphocytes
    Endocrine, vol. 20, no. 1-2, pp. 171–176, 2003
19. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls
    Journal of Neuroimmunology, vol. 137, no. 1-2, pp. 164–176, 2003
20. Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expression
    Journal of Neurocytology, vol. 32, no. 1, pp. 25–38, 2003
21. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study
    Clinical and Experimental Immunology, vol. 131, no. 1, pp. 155–168, 2003
22. Interferon-γ-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?
    Journal of Neuroimmunology, vol. 124, no. 1-2, pp. 70–82, 2002
23. Longitudinal study of antimyelin T-cell reactivity in relapsing–remitting multiple sclerosis: association with clinical and MRI activity
    Journal of Neuroimmunology, vol. 126, no. 1-2, pp. 143–160, 2002
24. Insights into the Immunopathogenesis of Multiple Sclerosis
    Immunologic Research, vol. 25, no. 1, pp. 27–52, 2002
25. The autoimmune pathogenesis of rheumatoid arthritis: Role of autoreactive T cells and new immunotherapies
    Seminars in Arthritis and Rheumatism, vol. 31, no. 3, pp. 160–175, 2001
26. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
    Journal of Neuroscience Research, vol. 63, no. 3, pp. 290–302, 2001
27. Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient
    Rheumatology, vol. 39, no. 11, pp. 1189–1201, 2000
28. Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations
    Journal of Neuroimmunology, vol. 102, no. 1, pp. 79–84, 2000
29. Lack of Association Between Estrogen Receptor Genotypes and Bone Mineral Density, Fracture History, or Muscle Strength in Elderly Women
    Journal of Bone and Mineral Research, vol. 14, no. 9, pp. 1576–1582, 1999
30. Cellular and Humoral Immune Responses Against Autoreactive T cells in Multiple Sclerosis Patients After T cell Vaccination
    Journal of Autoimmunity, vol. 13, no. 2, pp. 233–246, 1999
31. Identification of overrepresented T cell receptor genes in blood and tissue biopsies by PCR-ELISA
    Journal of Immunological Methods, vol. 223, no. 1, pp. 47–61, 1999
32. ?d T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination
    Journal of Neuroimmunology, vol. 87, no. 1-2, pp. 94–104, 1998
33. Cytokine profile of myelin basic protein?reactive T cells in multiple sclerosis and healthy individuals
    Annals of Neurology, vol. 42, no. 1, pp. 18–27, 1997
34. T cell vaccination: clinical application in autoimmune diseases
    Journal of Molecular Medicine, vol. 74, no. 11, pp. 653–662, 1996
35. Vaccination with autoreactive T cell clones in multiple sclerosis: overview of immunological and clinical data
    Journal of Neuroscience Research, vol. 45, no. 4, pp. 500–511, 1996
36. Activation and clonal expansion of human Myelin Basic Protein-reactive T cells by bacterial superantigens
    Journal of Autoimmunity, vol. 8, no. 4, pp. 615–632, 1995
37. Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis
    The Lancet, vol. 346, no. 8978, pp. 807–808, 1995
38. Superantigen Reactivity of ?d T Cell Clones Isolated from Patients with Multiple Sclerosis and Controls
    Cellular Immunology, vol. 166, no. 2, pp. 227–235, 1995
39. POLYMORPHISM OF THE TUMOUR NECROSIS FACTOR BETA GENE IN MULTIPLE SCLEROSIS AND RHEUMATOID ARTHRITIS
    European Journal of Immunogenetics, vol. 21, no. 5, pp. 377–382, 1994